Financial Consulate, Inc Oncolytics Biotech Inc Transaction History

Financial Consulate, Inc

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Oct 20, 2020	SELL	$1.58 - $2.15 $65,528 - $89,169	-41,474 Closed	0 $0
Q2 2020 Jul 22, 2020	BUY	$1.33 - $2.76 $55,160 - $114,468	41,474 New	41,474 $78,000

1.18M

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $49.2M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

Get notified when there are updates to the investment portfolio of Financial Consulate, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Consulate, Inc with notifications on news.